BIM
EW icon

Bridges Investment Management’s Edwards Lifesciences EW Stock Holding History

Bridges Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,976
Closed -$216K – 411
2025
Q1 		$216K Sell
2,976
-10,384
-78% -$743K ﹤0.01% 381
2024
Q4 		$989K Sell
13,360
-3,268
-20% -$229K 0.01% 208
2024
Q3 		$1.1M Sell
16,628
-58,619
-78% -$4.26M 0.02% 194
2024
Q2 		$6.95M Sell
75,247
-86,165
-53% -$7.63M 0.11% 95
2024
Q1 		$15.4M Sell
161,412
-9,726
-6% -$817K 0.48% 49
2023
Q4 		$13M Sell
171,138
-42,775
-20% -$2.98M 0.43% 51
2023
Q3 		$14.8M Sell
213,913
-8,729
-4% -$701K 0.53% 47
2023
Q2 		$21M Sell
222,642
-3,583
-2% -$311K 0.7% 38
2023
Q1 		$18.7M Buy
226,225
+10,049
+5% +$790K 0.66% 41
2022
Q4 		$16.1M Buy
216,176
+46,634
+28% +$3.59M 0.59% 46
2022
Q3 		$14M Buy
169,542
+298
+0.2% +$28.7K 0.54% 47
2022
Q2 		$16.1M Buy
169,244
+1,851
+1% +$192K 0.59% 45
2022
Q1 		$19.7M Buy
167,393
+3,152
+2% +$354K 0.61% 43
2021
Q4 		$21.3M Buy
164,241
+2,128
+1% +$248K 0.62% 43
2021
Q3 		$18.4M Buy
162,113
+163
+0.1% +$18.6K 0.58% 46
2021
Q2 		$16.8M Buy
161,950
+2,791
+2% +$263K 0.5% 51
2021
Q1 		$13.3M Buy
159,159
+20,241
+15% +$1.71M 0.39% 58
2020
Q4 		$12.7M Buy
138,918
+26,436
+24% +$2.19M 0.39% 56
2020
Q3 		$8.98M Buy
112,482
+13,484
+14% +$1.05M 0.3% 64
2020
Q2 		$6.84M Buy
98,998
+30,745
+45% +$2.18M 0.25% 70
2020
Q1 		$4.29M Buy
+68,253
New +$4.92M 0.19% 82
2019
Q3 		– Sell
-10,533
Closed -$649K – 422
2019
Q2 		$649K Buy
+10,533
New +$637K 0.02% 256

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Bridges Investment Management's EW Position: Q2 2025 in Review

Bridges Investment Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 2,976 shares — an estimated $216K sold.

Bridges Investment Management first reported a position in EW in Q2 2019 and held it in 22 quarters. The position peaked at $21.3M in Q4 2021. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Bridges Investment Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Bridges Investment Management sold 2,976 Edwards Lifesciences shares in Q2 2025, an estimated $216K.
  • Bridges Investment Management first reported a position in Edwards Lifesciences in Q2 2019 and held it in 22 quarters.
  • Bridges Investment Management's Edwards Lifesciences position peaked at $21.3M in Q4 2021.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Bridges Investment Management's 13F filing for Q2 2025, filed 28 Jul 2025.